Biocontrol Delivers Diasensor 1000 to the FDA.PITTSBURGH--(BUSINESS WIRE)--March 29, 1999--Biocontrol Technology Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:BICO BICO Bicolor ) announced today that a Diasensor 1000 Noninvasive Blood Glucose blood glucose Diabetology The principal sugar produced by the body from food–especially carbohydrates, but also from proteins and fats; glucose is the body's major source of energy, is transported to cells via the circulation and used by cells in the presence Monitor was delivered to the Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) following the conclusion of a technical seminar presented to FDA staff members at the Company's Indiana, Pa., facilities on March 23 and 24, 1999. The FDA purchased the Diasensor 1000, which is already approved for sale in the 15-country European Union, in order to evaluate its performance characteristics and conduct laboratory and clinical research on noninvasive monitoring. The purpose of the seminar was to educate the attending FDA staff members regarding the application, operation and maintenance of the device. Biocontrol bi·o·con·trol n. See biological control. biocontrol See biological control. will continue to assist the FDA, as requested, in their study of this new noninvasive technology. David L. Purdy, president of Biocontrol, stated, "The FDA personnel who attended the seminar were very knowledgeable about existing invasive glucose testing technology, and the Biocontrol presentation was designed to extend FDA personnel's understanding of the Company's noninvasive technology used in the Diasensor 1000. Both the FDA and Biocontrol personnel profited from the interchange of concepts embodied in the Diasensor." Biocontrol Technology has its corporate offices in Pittsburgh, Pa., and is involved in the development and manufacture of biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. devices and environmental products. Biocontrol has the exclusive rights to the research and development and manufacturing of the Diasensor 1000. Subsidiary Diasensor.com Inc., also located in Pittsburgh, Pa., owns the patent, marketing and distribution rights to the sensor. WEB SITE: www.bico.com INVESTOR RELATIONS NEWSLINE NUMBER: 800/357-6204 |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion